ロード中...
Sorafenib in metastatic radioactive iodine-refractory differentiated thyroid cancer: A pilot study
The incidence and mortality of thyroid cancer are on the increase worldwide and the treatment options for progressive, radioactive iodine (RAI)-refractory metastatic differentiated thyroid cancer (DTC) patients are currently limited. Sorafenib is a multikinase inhibitor that targets several molecula...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
D.A. Spandidos
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3916210/ https://ncbi.nlm.nih.gov/pubmed/24649313 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2013.199 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|